VIE - Business Development Coordinator (M/F)

Abolis-Biotechnologie; Boston (MA); On-site; USD 60,000 - 90,000; Full time

Benefits offered by this job

Monthly VIE allowance

Full social coverage

International experience

Job summary

Abolis Biotechnologies in Boston is seeking a VIE to support North American business development, identify opportunities and build relationships with prospective partners and clients in biotech ecosystems.

You will manage outreach, lead generation, market intelligence, and prepare pitches, while representing Abolis at trade shows and maintaining CRM records in a small, remote-friendly startup environment.

Qualifications

• Master’s degree in biotech/engineering or life sciences with business development focus.
• Fluent English; French is a plus for coordination with teams in France.
• Experience in international environments and startup context is a plus.

Responsibilities

• Identify opportunities and build relationships with prospective partners and clients in North America.
• Support outreach, lead generation, and qualification of prospects and industrial partners across sectors.
• Conduct market and competitive intelligence for partnerships, licensing, and joint development.
• Assist in preparing pitches, proposals, and technical/commercial presentations.
• Represent Abolis at trade shows, industry conferences, and networking events in the US.
• Maintain and update CRM records and report on pipeline activity.

Skills

Fluent English

Business development

CRM tools

Office suite

Education

Master's degree in biotech/engineering/life sciences

Tools

Office suite

CRM software

Job description

As part of our international growth strategy, we are opening a VIE position based in Boston, MA, to support the development of Abolis's business across North America.

Reporting to and working closely with Felipe Sarmiento, our Head of Business Development in the US, the VIE will play a key role in identifying opportunities, building relationships with prospective partners and clients, and helping establish Abolis's presence in one of the world's most dynamic biotech ecosystems.

• Supporting outreach, lead generation, and qualification of prospective clients and industrial partners across the food, cosmetics, healthcare, and specialty chemicals sectors in North America.

• Conducting market and competitive intelligence to identify partnership, licensing, and joint-development opportunities for Abolis's strain engineering platform, as well as M.I.N.E. software solution (previously known as Microbiome Studio).

• Assisting in the preparation of pitch materials, proposals, and technical/commercial presentations for prospects and partners

• Representing Abolis at trade shows, industry conferences, and networking events in the US

• Maintaining and updating CRM records and contributing to regular reporting on pipeline and business development activity

• Master's degree (or equivalent, Bac+5) from a biotech school, engineering school, university program, or life science cursus ideally with a specialization or strong interest a business and commercial development

• Previous international experience (internship, exchange, or prior VIE) is a plus

• Fluent English required; French is a plus for coordination with teams in France

• Comfortable engaging with scientific and technical content, and able to translate it into clear commercial arguments

• Strong communication, autonomy, and organizational skills; comfortable working independently in a small, remote team setup

• Proficiency in Office and CRM tools

• Entrepreneurial mindset, curiosity, and resilience — well suited to a fast-moving startup/scale-up environment

• Eligible for the VIE program: French or other EU/EEA national, aged 22+ at the time of application

Practical Information

• Location: Boston, MA, United States

• Contract type: VIE (Volontariat International en Entreprise), managed by Business France

• Duration: 12 months (possibility 18 months)

• Start date: Q4 2026

• Compensation: Monthly VIE allowance per Business France's official scale for the United States (a "dérogatoire" country with a specific indemnity level), tax-exempt in France, plus full social coverage

• Reporting line: Felipe Sarmiento, Head of BD, Abolis Biotechnologies